Idecabtagene vicleucel: questions regarding the appropriate role and cost

Kerrington Powell; David Russler-Germain; Vinay Prasad

doi:10.1111/bjh.17784

Idecabtagene vicleucel: questions regarding the appropriate role and cost

Kerrington Powell, David Russler-Germain, Vinay Prasad

Section of Medical Oncology

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	e15-e16
Journal	British Journal of Haematology
Volume	196
Issue number	2
DOIs	https://doi.org/10.1111/bjh.17784
State	Published - Jan 2022

Access to Document

10.1111/bjh.17784

Cite this

@article{ec7cc34ab34b4ffbbe9624e8c297616d,

title = "Idecabtagene vicleucel: questions regarding the appropriate role and cost",

author = "Kerrington Powell and David Russler-Germain and Vinay Prasad",

note = "Funding Information: This study was funded by Arnold Ventures. ",

year = "2022",

month = jan,

doi = "10.1111/bjh.17784",

language = "English",

volume = "196",

pages = "e15--e16",

journal = "British Journal of Haematology",

issn = "0007-1048",

number = "2",

}

TY - JOUR

T1 - Idecabtagene vicleucel

T2 - questions regarding the appropriate role and cost

AU - Powell, Kerrington

AU - Russler-Germain, David

AU - Prasad, Vinay

N1 - Funding Information: This study was funded by Arnold Ventures.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85112563835&partnerID=8YFLogxK

U2 - 10.1111/bjh.17784

DO - 10.1111/bjh.17784

M3 - Letter

C2 - 34402527

AN - SCOPUS:85112563835

SN - 0007-1048

VL - 196

SP - e15-e16

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 2

ER -

Idecabtagene vicleucel: questions regarding the appropriate role and cost

Access to Document

Other files and links

Cite this